Sevelamer versus calcium carbonate in incident hemodialysis patients: Results of an open-label 24-month randomized clinical trial

American Journal of Kidney Diseases

Volumn 62, Issue 4, 2013, Pages 771-778

  Di Iorio, Biagio ^a   Molony, Donald ^b   Bell, Cynthia ^b   Cucciniello, Emanuele ^a   Bellizzi, Vincenzo ^a   Russo, Domenico ^c   Bellasi, Antonio ^d  

^a UOC di Nefrologia   (Italy)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^d SANT ANNA HOSPITAL   (Italy)

Author keywords

Cardiovascular mortality; chronic kidney disease; coronary artery calcification; sevelamer

Indexed keywords

CALCIUM CARBONATE; SEVELAMER;

AGED; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DEATH; FEMALE; FOLLOW UP; HEART ARRHYTHMIA; HEMODIALYSIS; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; SURVIVAL; TREATMENT DURATION;

CARDIOVASCULAR MORTALITY; CHRONIC KIDNEY DISEASE; CORONARY ARTERY CALCIFICATION; SEVELAMER;

AGED; CALCIUM CARBONATE; CARDIOVASCULAR DISEASES; CORONARY ARTERY DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; POLYAMINES; RENAL DIALYSIS; SINGLE-BLIND METHOD; SURVIVAL RATE; TIME FACTORS;

EID: 84884532581     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2013.03.023     Document Type: Article

References (30)

1. K. Kalantar-Zadeh, N. Kuwae, D.L. Regidor Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients Kidney Int 70 4 2006 771 780
2. G.A. Block, P.S. Klassen, J.M. Lazarus Mineral metabolism, mortality, and morbidity in maintenance hemodialysis J Am Soc Nephrol 15 8 2004 2208 2218
3. G.A. Block, T.E. Hulbert-Shearon, N.W. Levin, F.K. Port Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study Am J Kidney Dis 31 4 1998 607 617
4. National Kidney Foundation K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease Am J Kidney Dis 42 4 2003 S1 S201 (suppl 3)
5. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD) Kidney Int Suppl 113 2009 S1 S130
6. T. Isakova, O.M. Gutierrez, Y. Chang Phosphorus binders and survival on hemodialysis J Am Soc Nephrol 20 2 2009 388 396
7. G.A. Block, D.M. Spiegel, J. Ehrlich Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis Kidney Int 68 4 2005 1815 1824
8. G.A. Block, P. Raggi, A. Bellasi, L. Kooienga, D.M. Spiegel Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients Kidney Int 71 5 2007 438 441
9. G.M. Chertow, S.K. Burke, P. Raggi Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients Kidney Int 62 1 2002 245 252
10. D. Russo, I. Miranda, C. Ruocco The progression of coronary artery calcification in predialysis patients on calcium carbonate or sevelamer Kidney Int 72 2 2007 1255 1261
11. W.N. Suki, R. Zabaneh, J.L. Cangiano Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients Kidney Int 72 9 2007 1130 1137
12. W.L. St Peter, J. Liu, E. Weinhandl, Q. Fan A comparison of sevelamer and calcium-based phosphate binders on mortality, hospitalization, and morbidity in hemodialysis: a secondary analysis of the Dialysis Clinical Outcomes Revisited (DCOR) randomized trial using claims data Am J Kidney Dis 51 3 2008 445 454
13. P. Raggi, J. Bommer, G.M. Chertow Valvular calcification in hemodialysis patients randomized to calcium-based phosphorus binders or sevelamer J Heart Valve Dis 13 1 2004 134 141
14. H.G. Asmus, J. Braun, R. Krause Two year comparison of sevelamer and calcium carbonate effects on cardiovascular calcification and bone density Nephrol Dial Transplant 20 8 2005 1653 1661
15. M. Tonelli, N. Wiebe, B. Culleton Systematic review of the clinical efficacy and safety of sevelamer in dialysis patients Nephrol Dial Transplant 22 10 2007 2856 2866
16. Q. Zhang, M. Li, Y. Lu Meta-analysis comparing sevelamer and calcium-based phosphate binders on cardiovascular calcification in hemodialysis patients Nephron Clin Pract 115 4 2010 c259 c267
17. B. Manns, L. Stevens, D. Miskulin A systematic review of sevelamer in ESRD and an analysis of its potential economic impact in Canada and the United States Kidney Int 66 10 2004 1239 1247
18. B. Di Iorio, O. Nargi, E. Cucciniello Coronary artery calcification progression is associated with arterial stiffness and cardiac repolarization deterioration in hemodialysis patients Kidney Blood Press Res 34 3 2011 180 187
19. M. Tonelli, N. Pannu, B. Manns Oral phosphate binders in patients with kidney failure N Engl J Med 362 14 2010 1312 1324
20. S.C. Palmer, J.C. Craig, G.F. Strippoli Sevelamer: a promising but unproven drug Nephrol Dial Transplant 22 10 2007 2742 2745
21. B.R. Di Iorio, E. Cucciniello, V. Bellizzi Vascular calcification and QT interval in incident hemodialysis patients J Nephrol 22 6 2009 694 698
22. W. Haverkamp, G. Breithardt, A.J. Camm The potential for QT prolongation and proarrhythmia by non-antiarrhythmic drugs: clinical and regulatory implications Report on a policy conference of the European Society of Cardiology Eur Heart J 21 15 2000 1216 1231
23. A.S. Agatston, W.R. Janowitz, F.J. Hildner Quantification of coronary artery calcium using ultrafast computed tomography J Am Coll Cardiol 15 4 1990 827 832
24. E.L. Kaplan, P. Meier Nonparametric estimation from incomplete observations J Am Stat Assoc 53 1958 457 481
25. H. Othmane Tel, G. Bakonyi, J. Egresits Effect of sevelamer on aortic pulse wave velocity in patients on hemodialysis: a prospective observational study Hemodial Int 11 suppl 3 2007 S13 S21
26. A. Bellasi, E. Ferramosca, C. Ratti Arterial stiffness in chronic kidney disease: the usefulness of a marker of vascular damage Int J Nephrol 2011 2011 734832
27. K.J. Claes, S. Heye, D. Nuyens Impact of vascular calcification on corrected QT interval at the time of renal transplantation Am J Nephrol 35 1 2012 24 30
28. W.N. Suki Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients: results of a randomized clinical trial J Ren Nutr 18 1 2008 91 98
29. B.R. Di Iorio, S. Bortone, C. Piscopo Cardiac vascular calcification and QT interval in ESRD patients: is there a link? Blood Purif 24 5-6 2006 451 459
30. R.S. Shantouf, M.J. Budoff, N. Ahmadi Total and individual coronary artery calcium scores as independent predictors of mortality in hemodialysis patients Am J Nephrol 31 5 2010 419 425